These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 18547553

  • 1. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
    Berend S, Vrdoljak AL, Radić B, Kuca K.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):413-6. PubMed ID: 18547553
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M, Vrdoljak AL, Radić B, Jelić D, Jun D, Kuca K, Kovarik Z.
    Toxicology; 2006 Feb 15; 219(1-3):85-96. PubMed ID: 16332406
    [Abstract] [Full Text] [Related]

  • 3. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J, Jun D, Karasova J, Bajgar J, Kuca K.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):425-7. PubMed ID: 18547554
    [Abstract] [Full Text] [Related]

  • 4. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
    Kovarik Z, Calić M, Sinko G, Bosak A, Berend S, Vrdoljak AL, Radić B.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):173-9. PubMed ID: 18501341
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J, Kuca K, Cabal J, Paar M.
    J Toxicol Environ Health A; 2006 Oct 25; 69(20):1875-82. PubMed ID: 16952906
    [Abstract] [Full Text] [Related]

  • 6. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A, Calić M, Radić B, Berend S, Jun D, Kuca K, Kovarik Z.
    Toxicology; 2006 Nov 10; 228(1):41-50. PubMed ID: 16982122
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.
    Toxicol Mech Methods; 2011 Mar 20; 21(3):241-5. PubMed ID: 21142778
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug 20; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 16. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J, Hajek P, Zdarova JK, Kassa J, Paseka A, Slizova D, Krs O, Kuca K, Jun D, Fusek J, Capek L.
    J Enzyme Inhib Med Chem; 2010 Dec 20; 25(6):790-7. PubMed ID: 21054236
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Kunesova G.
    J Appl Toxicol; 2006 Dec 20; 26(4):309-16. PubMed ID: 16552727
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.